Perioperative steroid use in colorectal patients - Results of a survey

Beck, David E. and Opelka, Frank G. (1996) Perioperative steroid use in colorectal patients - Results of a survey. Diseases of the Colon and Rectum, 39 9: 995-999. doi:10.1007/BF02054688


Author Beck, David E.
Opelka, Frank G.
Title Perioperative steroid use in colorectal patients - Results of a survey
Journal name Diseases of the Colon and Rectum   Check publisher's open access policy
ISSN 0012-3706
1530-0358
Publication date 1996-09-01
Year available 1996
Sub-type Article (original research)
DOI 10.1007/BF02054688
Open Access Status
Volume 39
Issue 9
Start page 995
End page 999
Total pages 5
Place of publication New York, NY, United States
Publisher Lippincott Williams & Wilkins
Language eng
Formatted abstract
PURPOSE:
A survey was conducted to document current perioperative steroid use in colorectal patients.

METHODS:

A mail survey was sent to 1,400 members and fellows of The American Society of Colon and Rectal Surgeons.

RESULTS:
Three hundred seven questionnaires (21.9 percent) were returned. Twenty-four respondents had retired or lacked accurate data. The remaining 283 surgeons averaged 43.5 (range, 31–71) years in age and had been in practice an average of 11 (range, 1–39) years. Ninety-seven percent were certified by the American Board of Surgery, 87 percent by the American Board of Colon and Rectal Surgery, and 85 percent by both. Eighty-six percent of respondents manage the perioperative steroids and 85 percent manage the postoperative steroid taper of their patients. In patients receiving preoperative steroids, 84 percent of respondents administer 100 mg of hydrocortisone phosphate intravenously before surgery. The most common postoperative dosage (used by 62 percent) was 100 mg of hydrocortisone phosphate intravenously every eight hours, which was tapered to 50 mg intravenously every 8 to 12 hours. Most patients (49 percent) received 20 mg of prednisone per day when their oral intake was resumed. The most common taper regimen was a 5 mg reduction per week (61 percent of respondents).

CONCLUSION:
Despite lack of scientifically established requirements or proven physiologic guidelines, perioperative steroid use by colorectal surgeons appears relatively consistent.
Keyword Steroid use
Perioperative medication
Colitis
Withdrawal
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Non-UQ

Document type: Journal Article
Sub-type: Article (original research)
Collection: School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 8 times in Thomson Reuters Web of Science Article | Citations
Google Scholar Search Google Scholar
Created: Mon, 14 Mar 2011, 18:46:30 EST